BTAI (STOCKS)
BioXcel Therapeutics, Inc. Common Stock
$1.610000
-0.050000 (-3.01%)
Prev close: $1.660000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Vimal D. Mehta
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $39.45M
- Employees
- 37
- P/E (TTM)
- -0.17
- P/B (TTM)
- -0.36
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-2.18 | $-1.20 | -0.9789 | -81.50% |
|
Jun 2025 (Q2)
|
$-2.45 | $-1.89 | -0.5569 | -29.42% |
|
Mar 2025 (Q1)
|
$-1.50 | $-6.79 | +5.2898 | +77.91% |
|
Dec 2024 (Q4)
|
$-3.57 | $-6.55 | +2.9835 | +45.53% |
Financial Statements
| Revenues | $752.00K |
| Benefits Costs and Expenses | $48.95M |
| Cost Of Revenue | $964.00K |
| Costs And Expenses | $51.42M |
| Gross Profit | -$212.00K |
| Operating Expenses | $50.46M |
| Selling, General, and Administrative Expenses | $20.78M |
| Research and Development | $29.45M |
| Other Operating Expenses | $226.00K |
| Operating Income/Loss | -$50.67M |
| Income/Loss From Continuing Operations After Tax | -$68.21M |
| Income/Loss From Continuing Operations Before Tax | -$51.53M |
| Net Income/Loss | -$68.21M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$68.21M |
| Net Income/Loss Available To Common Stockholders, Basic | -$68.21M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$9.04 |
| Diluted Earnings Per Share | -$9.04 |
| Basic Average Shares | 27,042,000 |
| Diluted Average Shares | 27,042,000 |
| Assets | $44.79M |
| Current Assets | $44.40M |
| Accounts Receivable | $0.00 |
| Inventory | $459.00K |
| Other Current Assets | $43.94M |
| Noncurrent Assets | $389.00K |
| Fixed Assets | $249.00K |
| Other Non-current Assets | $140.00K |
| Liabilities | $133.71M |
| Current Liabilities | $37.80M |
| Accounts Payable | $16.28M |
| Wages | $35.00K |
| Other Current Liabilities | $21.49M |
| Noncurrent Liabilities | $95.91M |
| Long-term Debt | $109.13M |
| Equity | -$88.92M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$88.92M |
| Liabilities And Equity | $44.79M |
| Net Cash Flow From Operating Activities | -$58.21M |
| Net Cash Flow From Operating Activities, Continuing | -$58.21M |
| Net Cash Flow From Investing Activities | $3.07M |
| Net Cash Flow From Investing Activities, Continuing | $3.07M |
| Net Cash Flow From Financing Activities | $55.15M |
| Net Cash Flow From Financing Activities, Continuing | $55.15M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$68.21M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$68.21M |
| Other Comprehensive Income/Loss | $0.00 |